A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biote Corp. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 15,457 shares of BTMD stock, worth $65,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,457
Previous 14,773 4.63%
Holding current value
$65,846
Previous $82,000 17.07%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.04 - $6.93 $3,447 - $4,740
684 Added 4.63%
15,457 $96,000
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $44,052 - $69,095
8,265 Added 127.0%
14,773 $82,000
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $35,403 - $48,614
6,508 New
6,508 $48,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $32.3M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.